11-124023335-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001953.1(OR10G9):c.323G>A(p.Ser108Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000264 in 1,589,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001953.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10G9 | NM_001001953.1 | c.323G>A | p.Ser108Asn | missense_variant | 1/1 | ENST00000375024.1 | NP_001001953.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10G9 | ENST00000375024.1 | c.323G>A | p.Ser108Asn | missense_variant | 1/1 | 6 | NM_001001953.1 | ENSP00000364164.1 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 4AN: 150312Hom.: 0 Cov.: 24
GnomAD3 exomes AF: 0.0000513 AC: 12AN: 234086Hom.: 0 AF XY: 0.0000472 AC XY: 6AN XY: 127234
GnomAD4 exome AF: 0.0000264 AC: 38AN: 1439484Hom.: 0 Cov.: 33 AF XY: 0.0000238 AC XY: 17AN XY: 715552
GnomAD4 genome AF: 0.0000266 AC: 4AN: 150312Hom.: 0 Cov.: 24 AF XY: 0.0000273 AC XY: 2AN XY: 73264
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.323G>A (p.S108N) alteration is located in exon 1 (coding exon 1) of the OR10G9 gene. This alteration results from a G to A substitution at nucleotide position 323, causing the serine (S) at amino acid position 108 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at